Patricia Verduin Sells 3833 Shares of Colgate-Palmolive Company (CL) Stock

Drilling down, the stock is 15.69% for the past month and 1.62% for the week.

11/15/2016 - Wells Fargo began new coverage on Colgate-Palmolive Company giving the company a "market perform" rating. In general, companies with the lowest combined rank may be the higher quality picks. Alpha Windward LLC now owns 2,829 shares of the company's stock valued at $207,000 after buying an additional 18 shares in the last quarter.

Colgate-Palmolive's chief executive recently signaled he would be open to selling the company - which has grappled with sluggish demand for its toothpaste, deodorants and food products - for $100 a share, a source told The Post. Further, company shares have been seen trading -13.61% off of the 52 week high and 54.59% away from the 52 week low. Monetary Mgmt Inc reported 0.27% in Colgate-Palmolive Company (NYSE:CL). The stock notched a 12-month high of $75.45 while $90.00 target is by far the most aggressive out of analysts who are now evaluating the company, $14.55 higher than the next highest 52-week price estimate. TIAA CREF Investment Management LLC increased its position in Colgate-Palmolive Company by 84.2% in the first quarter. Finally, Marshall Wace North America L.P. purchased a new position in Colgate-Palmolive Company during the first quarter valued at approximately $49,405,000. Analysts rating the company a 4 or 5 indicate a Sell recommendation. MA increased its position in Colgate-Palmolive Company by 7.5% in the first quarter. The stock was sold at an average price of $71.92, for a total value of $575,360.00.

04/06/2017 - Colgate-Palmolive Company had its "neutral" rating reiterated by analysts at Citigroup. The stock has jumped to over a 2-week high and has re-crossed its 50-day moving average. The stock has a market capitalization of $65.30 billion, a PE ratio of 26.68 and a beta of 0.70.

Shares of Colgate-Palmolive Company (NYSE:CL) traded down 2.33% during trading on Thursday, hitting $73.93. Closing price generally refers to the last price at which a stock trades during a regular trading session.

Colgate-Palmolive Company (NYSE:CL) last issued its earnings results on Friday, April 28th. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 1.5%. The analysts estimated sales for the higher end at 3955.86 million and lower end at 3814 million while the year ago reported sale was 4016.76 million. Private Advisor Grp Lc has 0.13% invested in Colgate-Palmolive Company (NYSE:CL). CRZO quarterly performance is -30.31% while firm's price to sale ratio is 3.11 and price to book ratio is 22.35. Analysts predict that Colgate-Palmolive Company will post $2.92 earnings per share for the current fiscal year. Shareholders of record on Friday, April 21st will be given a dividend of 0.40 per share on Monday, May 15th. This is a boost from Colgate-Palmolive Company's previous quarterly dividend of $0.39. They have a dividend yield of 2.20% and a 5 year dividend growth rate of 5.90%.

Now the P/E of Colgate-Palmolive Co. stands at 27.37. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and worldwide copyright law. Also, VP Daniel B. Marsili sold 14,000 shares of Colgate-Palmolive Company stock in a transaction on Monday, April 17th. Jefferies Group LLC started coverage on shares of Colgate-Palmolive Company in a research report on Tuesday, April 18th. BNP Paribas upgraded Colgate-Palmolive Company (NYSE:CL) on Friday, January 15 to "Outperform" rating. They now have a $76.67 target price on the stock. Fourteen analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Analysts rating the company a 3 indicate a Hold recommendation.

Earnings per share (EPS) breaks down the profitability of the company on a single share basis, and for Colgate-Palmolive Co. the EPS stands at 0.67 for the previous quarter, while the analysts predicted the EPS of the stock to be 0.66, suggesting the stock exceeded the analysts' expectations.

The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

While looking at the Stock's Performance, Colgate-Palmolive Co. now shows a Weekly Performance of 5.42%, where Monthly Performance is 2.33%, Quarterly performance is 10.92%, 6 Months performance is 14.96% and yearly performance percentage is 9.19%. 1,786 shares were sold by HUSTON JOHN J, worth $130,664.



Other news